• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

In vivo imaging characterizes differences in OVD retention


In vivo confocal microscopy was used to measure the thickness of ophthalmic viscosurgical devices (OVDs) retained beneath the corneal endothelium after phacoemulsification surgery. Results are reported for six different OVDs used in surgeries performed with varying fluidics settings.

Key Points

"Not surprisingly, the dispersive agents showed greater retention than the OVDs with more cohesive properties," said V. Vinod Mootha, MD, associate professor of ophthalmology, University of Texas Southwestern Medical Center.

Related Videos
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.